English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    S. O. Ostafiichuk, N. I. Henyk, O. V. Neiko, T. B. Snizhko, M. I. Rymarchuk, Yu. P. Vdovichenko

    MATERNAL ADIPOKINES AND INSULIN AS BIOMARKERS OF OBSTETRIC AND PERINATAL PATHOLOGY IN OVERWEIGHT WOMEN


    About the author: S. O. Ostafiichuk, N. I. Henyk, O. V. Neiko, T. B. Snizhko, M. I. Rymarchuk, Yu. P. Vdovichenko
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation Overweight women have an increased risk of decreased insulin sensitivity compared to normal weight women. In the study, it was shown that excessive gestational weight gain in prepregnancy overweight women is positively associated with increased production of leptin, resistin, and insulin, which are markers of insulin resistance and play an important role in the pathophysiology of gestational complications. It was proved that the chances of hyperleptinemia and hyperresistinemia increased in pregnant women with gestational hypertension and preeclampsia, especially in women with excessive gestational weight gain. In pregnant women with fetal growth retardation chances of insufficient leptin elevation in the second trimester increased in insufficient weight gain patients. A strong relationships between the concentration of leptin and resistin and the insulin resistance index in 22–24 weeks (r=0.83, p=0.000) and (r=0.83, p=0.000) and 37–39 weeks (r=0.86, p=0.000) and (r=0.84, p=0.000) were studied respectively. Due to insulin resistance, overweight women are at increased risk of metabolic dysregulation in pregnancy and associated negative results for the mother and fetus.
    Tags overweight women,adipokines,insulin resistance,reproductive health,obstetric and perinatal complications
    Bibliography
    • Nakaz MOZ Ukrayini No 151 vid 24.01.2022 “Hipertenzyvni rozlady pid chas vahitnosti, polohiv ta u pfslyapolohovomu periodi” [in Ukrainian]. https://www.dec.gov.ua/mtd/gipertenzyvni-rozlady-y-vagitnyh
    • Abraham T, Romani AMP. The relationship between obesity and pre-eclampsia: incidental risks and identification of potential biomarkers for pre-eclampsia. Cells. 2022;11;1548. doi:10.3390/ cells11091548
    • Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacoth. 2021;137;111315. doi:10.1016/j.biopha.2021.111315
    • Berger H, Melamed N, Davis BM, Hasan H, Mawjee K, Barrett J. Impact of diabetes, obesity and hypertension on preterm birth: population-based study. PLoS ONE. 2020;15(3):e0228743. doi:10.1371/journal. pone.0228743
    • Booth AM, Aaron FJ, Foster MT. Adipose tissue: an endocrine organ playing a role in metabolic regulation. Hormone Molec Biol Clinic Investig. 2016; 26 (1):25-42. doi:10.1515/hmbci-2015-0073
    • Costa MA. The endocrine function of human placenta: an overview. Reproductive Bio Medicine Online.2016;32:14–43.
    • Gutaj P, Sibiak R, Jankowski M, Awdi K, Bryl R, Mozdziak P, et.al. The role of the adipokines in the most common gestational complications. International Journal of Molecular Sciences. 2020;21(24):9408. doi:10.3390/ijms21249408
    • Hendler I, Blackwell SC, Mehta SH, Whitty JE, Russell E, Sorokin Y. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obst Gyn. 2005;193(3 Pt 2):979-83. doi:10.1016/j.ajog.2005.06.041
    • Lees CC, Stampalija T, Baschat AA, Costa F. da Silva, Ferrazzi E et.al. ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound Obstet Gynecol. 2020;56:298–312. doi: 10.1002/uog.22134
    • Mallardo M, Ferraro S, Daniele A. GDM-complicated pregnancies: focus on adipokines. Mol Biol Rep. 2021;48:8171–80. https://doi.org/10.1007/s11033-021-06785-0
    • Mishchenko VP, Rudenko IV, Likhachov VK, Gromova AM, Tarasenko KV. Folate cycle drugs in the complex preventive therapy for the miscarriage. World of medicine and biology. 2021;2(76):93-98. doi: 10.26724/2079-8334-2021-2-76-98-103
    • Mohsen M, Algohary EA, Hassan SH, El-Sherbeny AA, Abd El-Hadi EA, El-Kholy ALG. Study of possible relation between maternal serum resistin and insulin resistance in patients with preeclampsia. Egypt J Obes Diabetes Endocrinol. 2015;1:77-83.doi:10.4103/2356-8062.170205
    • Ostafiichuk SO. The role of resistin in the genesis of metabolic disorders in pathological pregnancy. The Ukrainian Biochemical Journal. 2019;5(91):48-55. doi: https://doi.org/10.15407/ubj91.05.055
    • Saneifard H, Radfar M, Shahrivar S, Shakiba M, Faraji N. Comparison of maternal serum and umbilical cord blood leptin level in IUGR neonates. Iran J Neonat. 2018;9(4):28-32. doi:10.22038/IJN.2018.29736.1403
    • Trivett C, Lees ZJ, Freeman DJ. Adipose tissue function in healthy pregnancy, gestational diabetes mellitus and pre-eclampsia. Eur J Clin Nutr. 2021;75(12):1745-56. doi: 10.1038/s41430-021-00948-9.
    Publication of the article «World of Medicine and Biology» №4(82), 2022 year, 133-138 pages, index UDK 618.3-06:612.015.32:612.397
    DOI 10.26724/2079-8334-2022-4-82-133-138